Emtricitabine-induced pure red cell aplasia.

adverse drug reaction antiretroviral drug induced emtricitabine pure red cell aplasia rare drug toxicity

Journal

Southern African journal of HIV medicine
ISSN: 2078-6751
Titre abrégé: South Afr J HIV Med
Pays: South Africa
ID NLM: 100965417

Informations de publication

Date de publication:
2019
Historique:
received: 10 05 2019
accepted: 10 06 2019
entrez: 17 10 2019
pubmed: 17 10 2019
medline: 17 10 2019
Statut: epublish

Résumé

Anemia is common in HIV. Parvo B19 infection is a well-recognised cause of red cell aplasia. Other causes of persistent pure red cell aplasia (PRCA) include anti-retroviral drugs such as zidovudine and lamivudine. We describe a case of PRCA that strongly implicates emtricitabine as the probable cause. Patient was HIV positive and on treatment with a fixed drug combination consisting of tenofovir, emtricitabine and efavirenz for 3 months when she developed severe transfusion dependent anemia. The anemia, attributed to PRCA, was persistent and transfusion dependent for about one year. Replacement of emtricitabine with abacavir resulted in a prompt, complete and lasting resolution of the anaemia, suggesting an etiologic role of emtricitabine in the PRCA. Emtricitibine is a rare cause of pure red cell aplasia.

Identifiants

pubmed: 31616574
doi: 10.4102/sajhivmed.v20i1.983
pii: HIVMED-20-983
pmc: PMC6779991
doi:

Types de publication

Case Reports

Langues

eng

Pagination

983

Informations de copyright

© 2019. The Authors.

Déclaration de conflit d'intérêts

The authors have no conflict of interests.

Références

AIDS. 2019 May 1;33(6):1095-1096
pubmed: 30946164
J Med Virol. 2019 Jul;91(7):1217-1223
pubmed: 30840773
AIDS. 1989 Mar;3(3):177-8
pubmed: 2496734
Am J Hematol. 2000 Nov;65(3):189-91
pubmed: 11074533
Am J Hematol. 1998 Jun;58(2):95-9
pubmed: 9625574
J Res Med Sci. 2012 Feb;17(2):138-42
pubmed: 23264786
J Med Microbiol. 2008 Aug;57(Pt 8):1032-5
pubmed: 18628508
AIDS. 1999 Aug 20;13(12):1586-7
pubmed: 10465087
Clin Infect Dis. 2013 Apr;56(7):968-77
pubmed: 23243178

Auteurs

Nithendra Manickchund (N)

King Edward VIII Hospital, Durban, South Africa.
Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.

Camille du Plessis (C)

King Edward VIII Hospital, Durban, South Africa.
Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.

Melanie-Anne A John (MA)

Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.

Thandekile C Manzini (TC)

Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.

Bernadett I Gosnell (BI)

King Edward VIII Hospital, Durban, South Africa.
Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.

Richard J Lessells (RJ)

Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa.
Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.

Yunus S Moosa (YS)

King Edward VIII Hospital, Durban, South Africa.
Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.

Classifications MeSH